Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial. (Q43272514)
Jump to navigation
Jump to search
scientific article published in March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial. |
scientific article published in March 2010 |
Statements
Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial (English)
Glen Clack
Richard D Finkelman
Martin Rimmer
Alan Swaisland
J Andrew Lockton